Astmabehandling i almen praksis

Victor Behrendt, Ole Hilberg, Vibeke Backer, Charlotte Suppli Ulrik, Niels Bjerring, Anders Løkke

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.
Bidragets oversatte titelAsthma treatment in general practice
TidsskriftUgeskrift for Læger
Udgave nummer11
Antal sider8
StatusUdgivet - 30. maj 2022


  • Administration, Inhalation
  • Adrenal Cortex Hormones/therapeutic use
  • Adult
  • Anti-Asthmatic Agents/adverse effects
  • Asthma/drug therapy
  • Drug Therapy, Combination
  • Ethanolamines/therapeutic use
  • Formoterol Fumarate/therapeutic use
  • General Practice
  • Humans


Dyk ned i forskningsemnerne om 'Astmabehandling i almen praksis'. Sammen danner de et unikt fingeraftryk.